ClinicalTrials.Veeva

Menu

Palliative Care in Patients With COVID-19: Analysis of Costs of Hospitalization in Wards and Intensive Care Units

U

University of Sao Paulo General Hospital

Status

Not yet enrolling

Conditions

COVID-19
Palliative Care

Treatments

Other: Analysis of costs with patient care during hospitalization

Study type

Observational

Funder types

Other

Identifiers

NCT05897229
31385420.6.1001.0068

Details and patient eligibility

About

The confrontation of COVID-19 foreshadowed a serious crisis of scarce health resources worldwide. To assist in this confrontation, the Palliative Care Scientific Technical Core of the Clinical Hospital, School of Medicine, Sao Paulo University (USP) elaborated a Triage Protocol for Palliative Care (PALI-COVID Tool) and it was possible to categorize the patients in three groups, according to the risk of death and needs of Palliative Care (PC), through the clinical evaluation of the patient that also directed them to the hospitalization resource according to their need (ward x ICU).

Full description

The patients grouped as with higher risk of death and PC needs (green group) by PALI-COVID Tool were those with a profile of end-of-life, signs of clinical deterioration and risk of death on admission and thus indicated for admission to the COVID-19 Palliative Care Inpatient Unit, however some were admitted to the ICU. Objective: to analyze the direct costs of hospitalization of COVID-19 Palliative Care patients in Palliative Care Inpatient Unit and ICU screened as green group by the COVID-19 Screening Protocol developed in the institution. Methods: observational, cross-sectional and retrospective study of the service database of patients over 18 years of age screened as the green group (PALI-COVID). The variables to be investigated are related to sociodemographic and clinical data, length of stay and hospitalization scenarios, time to call for PC, outcome and costs.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • inpatients with severe forms of COVID-19 between April 08 and July 31, 2020
  • positive reverse-transcriptase polymerase chain reaction (RT-PCR).
  • patients with terminal illness and high clinical risk of death before COVID-19.
  • those admitted to an ICU or palliative care unit.

Exclusion criteria

  • absence of hospitalization cost data in the institution's electronic records

Trial design

200 participants in 3 patient groups

PC - end-stage disease criteria and high risk of death from the disease prior to COVID-19
Description:
Patients with severe forms of COVID-19 (RT-PCR+) admitted to a high-complexity hospital. Of these, patients with end-stage disease criteria and high risk of death from the disease prior to COVID-19 were admitted, at clinical criteria, to palliative care unit. If there are patients who received both types of treatment, this group will also be analyzed.
Treatment:
Other: Analysis of costs with patient care during hospitalization
ICU - end-stage disease criteria and high risk of death from the disease prior to COVID-19
Description:
Patients with severe forms of COVID-19 (RT-PCR+) admitted to a high-complexity hospital. Of these, patients with end-stage disease criteria and high risk of death from the disease prior to COVID-19 were admitted, at clinical criteria, to the ICU. If there are patients who received both types of treatment, this group will also be analyzed.
Treatment:
Other: Analysis of costs with patient care during hospitalization
PC & ICU - end-stage disease criteria and high risk of death from the disease prior to COVID-19
Description:
Patients with severe forms of COVID-19 (RT-PCR+) admitted to a high-complexity hospital. Of these, patients with end-stage disease criteria and high risk of death from the disease prior to COVID-19 were admitted, at clinical criteria, to the ICU and palliative care unit. If there are patients who received both types of treatment, this group will also be analyzed.
Treatment:
Other: Analysis of costs with patient care during hospitalization

Trial contacts and locations

0

Loading...

Central trial contact

Ednalda M Franck, RN, MSc; Maria DC Otero Rodriguez, BSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems